Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

RADIO AIRPLAY AUDIENCE IMPRESSIONS AS PROVIDED BY LUMINATE AND SALES DATA AS COMPILED BY LUMINATE Tyla Last week Weeks at no. 1 Weeks on chart T.L.Seethal, I.Lewis, C.M.Lindsay-Keay, A.Irosogie ...

Both have been unexpected, and upsetting, side-effects of my decision last year to become one of the thousands of women turning to the weight-loss jab Mounjaro. I've heard of other users ...

Two of the most recommended meds nowadays that may aid in reducing weight are Mounjaro and Ozempic. But which one is better? Join us as we embark on a Mounjaro vs. Ozempic efficacy combat to ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

Though metrics such as GDP and job growth show a healthy economy, these seven charts offer insight into why Americans are still feeling crunched. Inflation has cooled significantly since its red ...

The analysis of 2.4mn patients bolsters research into how blockbuster drugs for obesity and diabetes such as Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro could have significant ...

The Top Albums chart is France’s main albums chart, compiled by Official Charts Company for SNEP and SCPP, based on sales, airplay and streams in France. View the full chart here.

Kiss surges to No. 2 on Billboard's Hard Rock Digital Song Sales chart as “I Was Made For Lovin’ ... [+] You” matches the band's all-time peak on the ranking. Gene Simmons, Ace Frehley ...